参考文献/References:
[1] Wu SM, Wu B, Liu M, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management[J]. Lancet Neurol, 2019, 18(4): 394-405.
[2] Tuttolomondo A. Ischemic stroke pathogenesis: genetics, epigenetics and inflammation[J]. Curr Pharm Des, 2020, 26(34): 4207-4208.
[3] Kim JS. Role of blood lipid levels and Lipid-Lowering therapy in stroke patients with different levels of cerebral artery diseases: reconsidering recent stroke guidelines[J]. J Stroke, 2021, 23(2): 149-161.
[4] Brooks DC, Schindler JL. Management of hyperlipidemia after stroke[J]. Curr Treat Options Cardiovasc Med, 2019, 21(12): 93.
[5] Huang YQ, Liu L, Liu XC, et al. The association of blood lipid parameters variability with ischemic stroke in hypertensive patients[J]. Nutr Metab Cardiovasc Dis, 2021, 31(5): 1521-1532.
[6] Zhao J, Lu W, Ren Y, et al. Apolipoprotein E regulates lipid metabolism and α-synuclein pathology in human iPSC-derived cerebral organoids[J]. Acta Neuropathol, 2021, 142(5): 807-825.
[7] Wu H, Huang Q, Yu Z, et al. The SNPs rs429358 and rs7412 of APOE gene are association with cerebral infarction but not SNPs rs2306283 and rs4149056 of SLCO1B1 gene in southern Chinese Hakka population[J]. Lipids Health Dis, 2020, 19(1): 202.
[8] Kumar A, Kumar P, Prasad M, et al. Association between Apolipoprotein ε4 Gene Polymorphism and Risk of Ischemic Stroke: A Meta-Analysis[J]. Ann Neurosci, 2016, 23(2): 113-121.
[9] Taghizadeh E, Ghayour-Mobarhan M, Ferns GA, et al. A novel variant in LPL gene is associated with familial combined hyperlipidemia[J]. Biofactors, 2020, 46(1): 94-99.
[10] Cao L, Li Q, Chen X. The HindIII and PvuII polymorphisms of lipoprotein lipase(LPL)gene reduce the risk of ischemic stroke(IS): A meta-analysis[J]. Medicine(Baltimore), 2018, 97(18): e0483.
[11] Kumari A, Kristensen KK, Ploug M, et al. The Importance of Lipoprotein Lipase Regulation in Atherosclerosis. Biomedicines, 2021, 9(7): 782.
[12] Ference BA, Kastelein J, Ray KK, et al. Association of Triglyceride-Lowering LPL variants and LDL-C-Lowering LDLR variants with risk of coronary heart disease[J]. JAMA, 2019, 321(4): 364-373.
[13] Wang C, Sun T, Li H, et al. Lipoprotein lipase Ser447Ter polymorphism associated with the risk of ischemic stroke: a meta-analysis[J]. Thromb Res, 2011, 128(5): e107-e112.
[14] Nettleton JA, Steffen LM, Ballantyne CM, et al. Associations between HDL-cholesterol and polymorphisms in hepatic lipase and lipoprotein lipase genes are modified by dietary fat intake in African American and White adults[J]. Atherosclerosis, 2007, 194(2): e131-e140.
[15] Wysocka A, Zwolak A. The relevance of noncoding DNA variations of paraoxonase gene cluster in Atherosclerosis-Related diseases[J]. Int J Mol Sci, 2021, 22(4): 2137.
[16] Didas N, Thitisopee W, Porntadavity S, et al. Arylesterase activity but not PCSK9 levels is associated with chronic kidney disease in type 2 diabetes[J]. Int Urol Nephrol, 2020, 52(9): 1725-1732.
[17] Xiao J, Li X, Yuan Q, et al. PON1 hypermethylation and PON3 hypomethylation are associated with risk of cerebral infarction[J]. Curr Neurovasc Res, 2019, 16(2): 115-122.
[18] Salari N, Rasoulpoor S, Hosseinian-Far A, et al. Association between serum paraoxonase 1 activity and its polymorphisms with multiple sclerosis: a systematic review[J]. Neurol Sci, 2021, 42(2): 491-500.
[19] Hansen KB, Staehr C, Rohde PD, et al. PTPRG is an ischemia risk locus essential for HCO(3)(-)-dependent regulation of endothelial function and tissue perfusion[J]. Elife, 2020, 9: e57553.
[20] Carty CL, Keene KL, Yc C, et al. Meta-Analysis of Genome-Wide association studies identifies genetic risk factors for stroke in African americans[J]. Stroke, 2015, 46(8): 2063-2068.
[21] Drieu A, Lanquetin A, Levard D, et al. Alcohol exposure-induced neurovascular inflammatory priming impacts ischemic stroke and is linked with brain perivascular macrophages[J]. JCI Insight, 2020, 5(4): 129226.
[22] Duan Y, Wang A, Wang Y, et al. Cumulative alcohol consumption and stroke risk in men[J]. J Neurol, 2019, 266(9): 2112-2119.
[23] Larsson SC, Wallin A, Wolk A, et al. Differing association of alcohol consumption with different stroke types: a systematic review and meta-analysis[J]. BMC Med, 2016, 14(1): 178.
[24] Qu Y, Zhang H, Li H, et al. Aldehyde dehydrogenase 2(ALDH2)Glu504Lys polymorphism affects collateral circulation and Short-Term prognosis of acute cerebral infarction patients[J]. Med Sci Monit, 2017, 23: 4559-4566.
[25] Jiang Y, He J, Liu H, et al. Association between ALDH2 rs671 polymorphism and risk of ischemic stroke: A protocol for systematic review and meta analysis[J]. Medicine(Baltimore), 2020, 99(21): e20206.
[26] Zhu CY, Wang Y, Zeng QX, et al. Combined effects of age and polymorphisms in Notch3 in the pathogenesis of cerebral infarction disease[J]. Metab Brain Dis, 2016, 31(5): 1157-1164.
[27] Alkattan A, Alsalameen E. Polymorphisms of genes related to phase-I metabolic enzymes affecting the clinical efficacy and safety of clopidogrel treatment[J]. Expert Opin Drug Metab Toxicol, 2021, 17(6): 685-695.
[28] 樊丹君,李晨怡,陈进,等.CYP2C19基因多态性与老年人脑梗死的相关性[J].中国医学科学院学报,2018,40(6):765-768.
[29] Wang Y, Meng X, Wang A, et al. Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA[J]. N Engl J Med, 2021, 385(27): 2520-2530.
[30] Sakata I, Takemi S. Ghrelin-cell physiology and role in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes, 2021, 28(2): 238-242.
[31] Chen L, Zhao H, Shen J, et al. Association between ghrelin gene polymorphism and cerebral infarction[J]. Med Sci Monit, 2020, 26: e924539.
[32] Qiu F, Wu Y, Zhang A, et al. Changes of coagulation function and risk of stroke in patients with COVID-19[J]. Brain Behav, 2021, 11(6): e02185.
[33] Winiewski A, Karczmarska-Wódzka A, Sikora J, et al. Hypercoagulability as measured by thrombelastography May be associated with the size of acute ischemic Infarct-A pilot study[J]. Diagnostics(Basel), 2021, 11(4): 712.
[34] Miller JR, Moon RT. Signal transduction through beta-catenin and specification of cell fate during embryogenesis[J]. Genes Dev, 1996, 10(20): 2527-2539.
[35] Katoh M. WNT2B:comparative integromics and clinical applications(Review)[J]. Int J Mol Med, 2005, 16(6): 1103-1108.
[36] Shi J, Tang J, Mu D Z. Bioinformatic analysis of differentially expressed genes involved in the post-hypoxic ischemic brain damage of newborn rats[J]. Sichuan Da Xue Xue Bao Yi Xue Ban, 2016, 47(5): 722-726.
[37] Yuan H, Fan P, Yao L, et al. Contribution of WNT2B genetic variants to ischemic stroke occurrence in a Chinese Han population[J]. J Cardiovasc Pharmacol, 2021, 78(1): e128-e135.
[38] Zhang T, Jiang Y, Zhang S, et al. The association between homocysteine and ischemic stroke subtypes in Chinese: A meta-analysis[J]. Medicine(Baltimore), 2020, 99(12): e19467.
[39] Qin X, Spence JD, Li J, et al. Interaction of serum vitamin B(12)and folate with MTHFR genotypes on risk of ischemic stroke[J]. Neurology, 2020, 94(11): e1126-e1136.
[40] Li B, Li Y, Xu S, et al. A comprehensive association analysis between homocysteine metabolic pathway gene methylation and ischemic stroke in a Chinese hypertensive population[J]. J Clin Lab Anal, 2021, 35(3): e23689.
[41] Gou Y, Ye Q, Liang X, et al. Homocysteine restrains hippocampal neurogenesis in focal ischemic rat brain by inhibiting DNA methylation[J]. Neurochem Int, 2021, 147: 105065.
[42] Fekih-Mrissa N, Mrad M, Klai S, et al. Methylenetetrahydrofolate reductase(C677T and A1298C)polymorphisms, hyperhomocysteinemia, and ischemic stroke in Tunisian patients[J]. J Stroke Cerebrovasc Dis, 2013, 22(4): 465-469.
[43] Su Q, Weindl G. Glucocorticoids and toll-like receptor 2 cooperatively induce acute-phase serum amyloid a[J]. Pharmacological Research, 2018, 128: 145-152.
[44] Shridas P, Tannock LR. Role of serum amyloid A in atherosclerosis[J]. Curr Opin Lipidol, 2019, 30(4): 320-325.
[45] Sack GJ. Serum amyloid A-a review[J]. Mol Med, 2018, 24(1): 46.
[46] Xie X, Ma YT, Yang YN, et al. Polymorphisms in the SAA1/2 gene are associated with carotid intima media thickness in healthy Han Chinese subjects: the cardiovascular risk survey[J]. PLoS One, 2010, 5(11): e13997.
[47] Zhao J, Piao X, Wu Y, et al. Association of SAA gene polymorphism with ischemic stroke in northern Chinese Han population[J]. J Neurol Sci, 2017, 380: 101-105.
[48] Cappella M, Ciotti C, Cohen-Tannoudji M, et al. Gene therapy for ALS-A perspective[J]. Int J Mol Sci, 2019, 20(18): 4388.
[49] Tang S, Bai L, Zheng SJ. Research progress in gene therapy for Wilson's disease[J]. Zhonghua Gan Zang Bing Za Zhi, 2021, 29(1): 21-24.
[50] Feneberg E, Otto M. Gene-specific treatment approaches in Alzheimer's disease and other tauopathies[J]. Nervenarzt, 2020, 91(4): 312-317.
[51] Chen W, Hu Y, Ju D. Gene therapy for neurodegenerative disorders: advances, insights and prospects[J]. Acta Pharm Sin B, 2020, 10(8): 1347-1359.